On Friday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was 6.20% up from the session before settling in for the closing price of $40.49. A 52-week range for SWTX has been $28.21 – $53.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -25.00% over the past five years. When this article was written, the company’s average yearly earnings per share was at 39.43%. With a float of $65.95 million, this company’s outstanding shares have now reached $74.34 million.
Let’s look at the performance matrix of the company that is accounted for 305 employees. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.
SpringWorks Therapeutics Inc (SWTX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 11.43%, while institutional ownership is 101.71%. The most recent insider transaction that took place on Dec 03 ’24, was worth 839,336. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $41.97, taking the stock ownership to the 209,600 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Executive Officer sold 49,000 for $41.37, making the entire transaction worth $2,027,357. This insider now owns 1,014,368 shares in total.
SpringWorks Therapeutics Inc (SWTX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 39.43% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.12 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
SpringWorks Therapeutics Inc (NASDAQ: SWTX) saw its 5-day average volume 2.41 million, a positive change from its year-to-date volume of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 57.86%. Additionally, its Average True Range was 2.49.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 84.81%, which indicates a significant increase from 76.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.67% in the past 14 days, which was higher than the 45.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.15, while its 200-day Moving Average is $38.33. Nevertheless, the first resistance level for the watch stands at $45.19 in the near term. At $47.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $50.77. If the price goes on to break the first support level at $39.62, it is likely to go to the next support level at $36.24. The third support level lies at $34.04 if the price breaches the second support level.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 74,386K outstanding shares of the company, which has a market capitalization of 3.20 billion. As of now, sales total 5,450 K while income totals -325,100 K. Its latest quarter income was 49,300 K while its last quarter net income were -53,530 K.
